Home
 /
Papers
 /
Genetics
 /
Genetic variation reveals a homeotic long noncoding RNA that modulates human hematopoietic stem cells
Preprint
Open access
V1
Top 1% · Validated by QED

Genetic variation reveals a homeotic long noncoding RNA that modulates human hematopoietic stem cells

Peng Lyu, Gaurav Agarwal, Chun-Jie Guo +11 more
April 2026
 ·
bioRxiv
 ·
DOI 
10.1101/2025.07.16.664824
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Genetics this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By showing that a common variant dismantles a lncRNA-SRSF2 splicing axis controlling HOXA9, this work demonstrates that noncoding human variation directly governs HSC self-renewal—transforming how we read the genome for blood cancer risk.

Author perspective

What is the most important insight, discovery, or finding from your paper that you would like other scientists to know?
“

We have uncovered a genetic mechanism that protects blood stem cells from expanding with cancer-causing mutations. Critically, this also identifies a poorly characterized long non-coding RNA in the HOXA locus that has a key role in stem cell regulation.

”
Vijay G. Sankaran

QED claims analysis

Summary

A naturally occurring genetic variant (rs17437411) in the previously uncharacterized lncRNA HOTSCRAMBL disrupts its secondary structure and impairs SRSF2-mediated splicing of HOXA9, thereby reducing human hematopoietic stem cell self-renewal and conferring protection against blood cancers while also compromising HOXA-dependent acute myeloid leukemia growth.

See full analysis
Main Claim 1 –

HOTSCRAMBL rs17437411 Associates with Low Blood Counts, Cancer Protection

Supporting evidence

  • HOTSCRAMBL Is HSC-Enriched and Predominantly Nuclear
Main Claim 2 –

HOTSCRAMBL rs17437411 Reduces HSC Self-Renewal, Promotes Differentiation

Supporting evidence

  • HOTSCRAMBL rs17437411 Impairs Long-Term HSC Engraftment In Vivo
  • rs17437411 Acts Through HOTSCRAMBL RNA with Dominant-Negative Effects
Main Claim 3 –

HOTSCRAMBL Controls HSCs via HOXA9 Splicing and Expression

Main Claim 4 –

HOTSCRAMBL Promotes SRSF2-Dependent HOXA9 Splicing via Direct Binding

Supporting evidence

  • HOTSCRAMBL Disruption Restrains HOXA-Dependent AML Growth and Differentiation

Abstract

The HOXA gene locus coordinates body patterning, hematopoiesis, and differentiation. While studying blood phenotype-associated variation within the HOXA locus, we identified a genetic variant, rs17437411, associated with globally reduced blood counts, protection from blood cancers, and variation in anthropometric phenotypes. We find that this variant disrupts the activity of a previously unstudied antisense long non-coding RNA (lncRNA) located between HOXA7 and HOXA9, which we have named HOTSCRAMBL. The HOTSCRAMBL variant disrupts lncRNA function and reduces human hematopoietic stem cell (HSC) self-renewal. Mechanistically, HOTSCRAMBL enables appropriate expression and splicing of HOXA genes in HSCs, most notably HOXA9, in an SRSF2-dependent manner. Given the critical role of HOXA gene expression in some blood cancers, we also demonstrate that HOTSCRAMBL variation or deletion compromises HOXA-dependent acute myeloid leukemias. Collectively, we show how insights from human genetic variation can uncover critical regulatory processes required for effective developmental gene expression.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?